Orinda Asset Management’s Biogen BIIB Stock Holding History

Orinda Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-961	Closed	-$301K	–	42
2016 Q3	$301K	Buy	+961	New	+$285K	0.26%	39
2016 Q1	–	Sell	-390	Closed	-$119K	–	67
2015 Q4	$119K	Buy	+390	New	+$112K	0.17%	73
2015 Q3	–	Sell	-279	Closed	-$113K	–	129
2015 Q2	$113K	Buy	+279	New	+$112K	0.13%	85
2014 Q4	–	Sell	-440	Closed	-$146K	–	114
2014 Q3	$146K	Sell	440 -123	-22%	-$40.6K	0.24%	64
2014 Q2	$178K	Sell	563 -91	-14%	-$27.4K	0.34%	57
2014 Q1	$200K	Sell	654 -259	-28%	-$82.2K	0.43%	49
2013 Q4	$255K	Sell	913 -70	-7%	-$18.1K	0.57%	36
2013 Q3	$236K	Buy	+983	New	+$220K	0.74%	31

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Orinda Asset Management's BIIB Position: Q4 2016 in Review

Orinda Asset Management sold out of Biogen (BIIB) in Q4 2016, closing a stake of 961 shares — an estimated $301K sold.

Orinda Asset Management first reported a position in BIIB in Q3 2013 and held it in 8 quarters. The position peaked at $301K in Q3 2016. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

Orinda Asset Management reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
Orinda Asset Management sold 961 Biogen shares in Q4 2016, an estimated $301K.
Orinda Asset Management first reported a position in Biogen in Q3 2013 and held it in 8 quarters.
Orinda Asset Management's Biogen position peaked at $301K in Q3 2016.
1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Orinda Asset Management's 13F filing for Q4 2016, filed 30 Jan 2017.